, and 1 × 10 -3 M cerium(IV), with (black traces) or without (red traces) 1 × 10 -6 M ofloxacin. The intensity of the red trace in figure S2 (b) was multiplied by 5 for comparison purposes. The stopped-flow manifold was constructed as previously described (Anal. Chem., 2010 , 82, 2580 -2584 . Discrepeancies in the signal/blank ratios obtained in these experiments and the flow-injection analysis procedure described in the paper arise due to differences in the final reactant concentrations, the mode of mixing and the portion of the emission profile measured. Experimental details: the injection loop (70 L) was filled with reagent and ofloxacin solutions (combined 1:1 (v/v) off-line). The syringe pump was then activated to dispense 120 L of carrier (1:1 acetonitrile:water) and 120 L of oxidant (1 × 10 -3 M cerium(IV) in 0.05 M H2SO4) solutions at a rate of 10 mL min -1 per line, which rapidly merged the three reactants in a dual-inlet serpentine flow-cell, where the emission was monitored over time. ESI-3 
